Related Experiment Video
Updated: Jul 12, 2025

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
α-Synuclein aggregates amplified from patient-derived Lewy bodies recapitulate Lewy body diseases in mice
Norihito Uemura1, Nicholas P Marotta2, Jahan Ara2
1Department of Pathology and Laboratory Medicine, Institute on Aging and Center for Neurodegenerative Disease Research, University of Pennsylvania School of Medicine, Philadelphia, PA, 19104-2676, USA. nuemura@kuhp.kyoto-u.ac.jp.
Abstract:
Extraction of α-Synuclein (αSyn) aggregates from Lewy body disease (LBD) brains has been widely described yet templated fibrillization of LB-αSyn often fails to propagate its structural and functional properties. We recently demonstrated that aggregates amplified from LB-αSyn (ampLB) show distinct biological activities in vitro compared to human αSyn preformed fibrils (hPFF) formed de novo. Here we compare the in vivo biological activities of hPFF and ampLB regarding seeding activity, latency in inducing pathology, distribution of pathology, inclusion morphology, and cell-type preference. Injection of ampLB into mice expressing only human αSyn (male Thy1:SNCA/Snca-/- mice) induced pathologies similar to those of LBD subjects that were distinct from those induced by hPFF-injection or developing spontaneously with aging. Importantly, αSyn aggregates in ampLB-injected Thy1:SNCA/Snca-/- mice maintained the unique biological and conformational features of original LB-αSyn. These results indicate that ampLB-injection, rather than conventional PFF-injection or αSyn overexpression, faithfully models key aspects of LBD.
Insights
Amplified Lewy body alpha-Synuclein (αSyn) aggregates accurately model Lewy body disease (LBD) pathology in mice. This new model preserves the unique biological and conformational features of αSyn found in LBD brains.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Extraction of alpha-Synuclein (αSyn) aggregates from Lewy body disease (LBD) brains is established, but replicating their properties via templated fibrillization is challenging.
- Amplified LB-αSyn (ampLB) exhibits distinct in vitro biological activities compared to de novo human αSyn preformed fibrils (hPFF).
Purpose of the Study:
- To compare the in vivo biological activities of hPFF and ampLB.
- To evaluate their efficacy in modeling Lewy body disease (LBD) pathology.
Main Methods:
- Injection of ampLB and hPFF into mice expressing human αSyn (Thy1:SNCA/Snca-/-).
- Assessment of seeding activity, pathology latency, distribution, inclusion morphology, and cell-type preference.
- Analysis of αSyn aggregate features in injected mice.
Main Results:
- ampLB injection induced LBD-like pathologies distinct from hPFF injection or aging.
- Pathologies in ampLB-injected mice mimicked those in human LBD subjects.
- αSyn aggregates in ampLB-injected mice retained original LB-αSyn biological and conformational features.
Conclusions:
- ampLB injection serves as a faithful model for key aspects of Lewy body disease (LBD).
- This approach is superior to conventional PFF injection or αSyn overexpression for LBD modeling.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Neural Regulation

